Archives of Pharmacal Research

The Pharmaceutical Society of Korea (대한약학회)
권호 표지

Pharmacokinetics and Bioavailability of Oral Cephalosporins, KR-984055 and its Prodrugs, KR-999001 and KR-999002, in the Red

  • Published : 2003.01.01
Download PDF
⟨ Previous Next ⟩

Abstract

KR-984055 is a new oral cephalosporin antibiotic with activity against both gram-positive and gram-negative bacteria. Lipophilic ester-type prodrugs of KR-984055, i.e., KR-999001 and KR-999002, have been synthesized in an attempt to increase the oral bioavailability of this broad-spectrum antibiotic agent. In this study we determined the oral bioavailability of KR-984055 and its prodrugs in the rat, and evaluated the pharmacokinetic model that best describes the plasma concentration behavior following single intravenous (IV) and oral single dose. In addition, concentrations in plasma as well as biliary and urinary recovery of KR-984055 were determined. Also, protein binding of KR-984055 in plasma was examined in vitro. The degree of protein binding of KR-984055 was in the range of 92.09~94.77%. KR-984055 exhibited poor oral bioavailability (7.02$\pm$1.58%). The observed oral bioavailabilities of KR-984055 from KR-999001 and KR-999002 were 38.77$\pm$2.81 % and 39.81$\pm$5.25%, respectively. These data were calculated from the levels of free KR-984055 in plasma. Oral KR-999001 and KR-999002 were not recovered from plasma, suggesting that it was readily cleaved to free KR-984055. KR-999001 and KR-999002 appear to be an efficient oral prod rug of KR-984055 that deserved further clinical evaluation in human.

Keywords

References

  1. Campbell, J., Chantrell, L. J. and Eastmond, R., Purification and partial characterization of rat intestinal cefuroxime axetil esterase. Biochem. Pharmacol., 36, 2317-2324 (1987) https://doi.org/10.1016/0006-2952(87)90597-1
  2. Gabrielsson, J. and Weiner, D., Pharmacokinetic and Pharmacodynamic data analysis: Concepts and applications. Swedich Pharmaceutical Press, Stockholm, (1997)
  3. Li, W., Escarpe, P. A., Eisenberg, E. J., Cundy, K. C., Sweet, C., Jakeman, K. J., Merson, J., Lew, W., Williams, M., Zhang, L., Kim, C. U., Bischofberger, N., Chen, M. S. and Mendel, D. B., Identification of GS 4104 as an orally bioavailable produrg of the influenza virus neuraminidase inhibitor GS 4071. Antimicrobial Agents and Chemotherapy, 42(3), 647-653 (1998) https://doi.org/10.1093/jac/42.5.647
  4. Micropartition system MPS-1: For separation of free from protein-bound microsolute. Amicon Division, W.R. Grace & Co., USA.
  5. Naesens, L., Balzarini, J., BIschofberger, N. and De Clercq, E., Antiretroviral activity and pharmacokinetics in mice of oral bis (pivaloyloxymethyl)-9-(2-phosphonylmethoxyethyl)adenine, the bis(povaloyloxymethyl) ester prodrug of 9-(2-phosphonylmethoxyethyl) adenine. Antimicrobial Agents and Chemotherapy, 40, 22-28 (1996)
  6. Ruiz-Carretero, P., Nacher, A., Merino-Sanjuan, M. and Casabo, V. G., Pharmacokinetics and absolute bioavailability of oral cefuroxime axetil in the rat. International Journal of pharmaceutics, 202, 89-96 (2000) https://doi.org/10.1016/S0378-5173(00)00420-8
  7. Okudaira, N., Tatebayashi, T., Speirs, G. C., Komiya, I.. and Sugiyama, Y., A study of the intestinal absorption of an estertype prodrug, ME3229, in rats: active efflux transport as a cause of poor bioavailability of the active drug. The Journal of Pharmacology and Experimental Therapeutics, 294, 580-587 (2000)
  8. Shargel, L. and Yu, A., Applied Biopharmaceutics and Pharmacokinetics. Appleton & Lange, Stamford, (1999)
  9. Stoeckel, K., Hofheinz, W., Laneury, J. P., Duchene, P., Shedlofsky, S. and Blouin, R. A., Stability of cephalosporin prodrug esters in human intestinal juice: Implications for oral bioavailability. Antimicrobial Agents and Chemotherapy, 42, 2602-2606 (1998)
  10. Umemura, K., Ikeda, Y., Kondo, K., Nakashima, M., Naganuma, H., Hisaoka, M., Nishino, H. and Tajima, M., Safety and pharmacokinetics of CS-834, a new oral carbapenem antibiotic, in healthy volunteers. Antimicrobial Agents and Chemotherapy, 41, 2664-2669 (1997)
  11. Wilkins, J., Ashofteh, A., Setoda, D., Wheatley, W. S., Huigen, H. and Ling, W., Ultrafiltration using the Amicon MPS-1 for assessing methadone plasma protein binding. Ther Drug Monit., 19(1), 83-87 (1997) https://doi.org/10.1097/00007691-199702000-00015